Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01244750
Title Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

chronic myeloid leukemia

Therapies

Imatinib

Dasatinib

Nilotinib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.